Events

25 June 2019

APA/RIPS Webinar: CVS/90-Day Supply Issue Follow-Up

1:30 p.m. - 2:30 p.m.

Conference Call

+ Event Details

25 June 2019

APA/RIPS Webinar: CVS/90-Day Supply Issue Follow-Up

Dear Doctors,


We understand there have been occasions when CVS has filled a 30-day prescription for 90 days and for some of your patients this practice is not in their best interests. We would like to address this with CVS, but before doing so we need your help with the following:


1. We need specific stories of how this practice has been harmful or potentially harmful to one of your patients. We need these stories to come from the treating physician and include the following information:

  • Your patient’s diagnosis
  • Name of medication and dosage you prescribed
  • Where/When was the prescription filled for 90 days, instead of 30 days
  • Why was it harmful or could have been harmful to this specific patient that he/she have access to a 90-day supply of this particular drug?


2. Whether anyone is aware of studies showing the risk of suicide or harm for patients who have access to larger quantities of medications. 


3. The contact information for the doctors who responded to the survey on this listserv and submitted the narratives below:

  • I treated a 13 y/o girl with a history of SI, and CVS required me to dispense a 90-day supply of lamotragine to the patient stating that the patient would have to pay out-of-pocket for a 30-day supply, “therefore a 90-day supply was required.” This med is lethal in overdose.
  • I work for 2 colleges in the area and do not prescribe 90 days due to students going home for the summer when they are not under my care and need to be under the care of a provider in their home town
  • I have many patients who are intermittently suicidal and having a 90-day supply of medication is a serious liability.


In the interest of collecting this information in a most time efficient manner, we will be hosting two conference calls: Tuesday, June 25 at 1:30 p.m. EDT or Thursday, June 27 at 2:15 p.m. EDT.  


Call-in number: 1-202-602-1295 ID: 733-481-365#


The purpose of these two calls is to collect the information in items 1, 2, and 3 above.


Thank you.


Maureen A. Maguire, JD

Associate Director — Policy and Practice Advocacy

American Psychiatric Association

800 Maine Avenue SW, Suite 900

Washington, DC 20002

1:30 p.m. - 2:30 p.m.

Conference Call

27 June 2019

APA/RIPS Webinar: CVS/90-Day Supply Issue Follow-Up

2:15 p.m. - 3:15 p.m.

Conference Call

+ Event Details

27 June 2019

APA/RIPS Webinar: CVS/90-Day Supply Issue Follow-Up

Dear Doctors,


We understand there have been occasions when CVS has filled a 30-day prescription for 90 days and for some of your patients this practice is not in their best interests. We would like to address this with CVS, but before doing so we need your help with the following:


1. We need specific stories of how this practice has been harmful or potentially harmful to one of your patients. We need these stories to come from the treating physician and include the following information:

  • Your patient’s diagnosis
  • Name of medication and dosage you prescribed
  • Where/When was the prescription filled for 90 days, instead of 30 days
  • Why was it harmful or could have been harmful to this specific patient that he/she have access to a 90-day supply of this particular drug?

2. Whether anyone is aware of studies showing the risk of suicide or harm for patients who have access to larger quantities of medications. 


3. The contact information for the doctors who responded to the survey on this listserv and submitted the narratives below:

  • I treated a 13 y/o girl with a history of SI, and CVS required me to dispense a 90-day supply of lamotragine to the patient stating that the patient would have to pay out-of-pocket for a 30-day supply, “therefore a 90-day supply was required.” This med is lethal in overdose.
  • I work for 2 colleges in the area and do not prescribe 90 days due to students going home for the summer when they are not under my care and need to be under the care of a provider in their home town
  • I have many patients who are intermittently suicidal and having a 90-day supply of medication is a serious liability.

In the interest of collecting this information in a most time efficient manner, we will be hosting two conference calls: Tuesday, June 25 at 1:30 p.m. EDT or Thursday, June 27 at 2:15 p.m. EDT

 
Call-in number: 1-202-602-1295 ID: 733-481-365#


The purpose of these two calls is to collect the information in items 1, 2, and 3 above.


Thank you.


Maureen A. Maguire, JDAssociate Director — Policy and Practice Advocacy

American Psychiatric Association

800 Maine Avenue SW, Suite 900

Washington, DC 20002


2:15 p.m. - 3:15 p.m.

Conference Call

16 Sep 2019

Council Meeting

+ Event Details

16 Sep 2019

Council Meeting


15 Oct 2019

Membership Meeting

+ Event Details

15 Oct 2019

Membership Meeting


9 Dec 2019

Membership Meeting

+ Event Details

9 Dec 2019

Membership Meeting